Literature DB >> 3106406

Production and characterization of monoclonal antibodies to toxic shock syndrome toxin 1 and use of a monoclonal antibody in a rapid, one-step enzyme-linked immunosorbent assay for detection of picogram quantities of toxic shock syndrome toxin 1.

D E Wells, M W Reeves, R M McKinney, L M Graves, O Olsvik, T Bergan, J C Feeley.   

Abstract

Twenty-six hybridoma cell lines that produced monoclonal antibodies to toxic shock syndrome toxin 1 (TSST-1) were generated by immunizing mice with a highly purified preparation of TSST-1 and fusing their splenic lymphocytes with SP2/0-Ag-14 cells. One monoclonal antibody of the immunoglobulin G1 isotype, designated as PEC-1 10-2SCH, was selected for extensive study. The specificity of this antibody was determined by testing spent culture fluid filtrates of TSST-1- and non-TSST-1-producing strains of Staphylococcus aureus by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and enzyme-linked immunoelectrotransfer blot techniques. Monoclonal antibody PEC-1-10-2SCH was specific for TSST-1-producing strains of S. aureus, reacting with TSST-1 and two other proteins which appear to be unique to S. aureus strains that produce TSST-1. Monoclonal antibody PEC-1-10-2SCH was used in conjunction with polyclonal rabbit antibodies to TSST-1 in a rapid, one-step, sensitive, specific, and quantitative enzyme-linked immunosorbent assay. This assay was shown to be more sensitive, faster, and simpler to perform than previously described isoelectric focusing, immunodiffusion, and solid-phase radioimmunoassays for TSST-1. Monoclonal antibody PEC-1-10-2SCH was not reactive with Staphylococcus protein A under the conditions of the test.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106406      PMCID: PMC265972          DOI: 10.1128/jcm.25.3.516-521.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Demonstration of species-specific and cross-reactive components of the adult microsomal antigens from Schistosoma mansoni and S. japonicum (MAMA and JAMA).

Authors:  V C Tsang; K Hancock; S E Maddison; A L Beatty; D M Moss
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

2.  Transport and processing of staphylococcal alpha-toxin.

Authors:  R K Tweten; K K Christianson; J J Iandolo
Journal:  J Bacteriol       Date:  1983-11       Impact factor: 3.490

3.  Transport and processing of staphylococcal enterotoxin B.

Authors:  R K Tweten; J J Iandolo
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

4.  Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis.

Authors:  V C Tsang; J M Peralta; A R Simons
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Rapid screening assay for toxic shock syndrome toxin production by Staphylococcus aureus.

Authors:  L S Weckbach; M R Thompson; J L Staneck; P F Bonventre
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

6.  A rabbit model of toxic shock syndrome: clinicopathological features.

Authors:  R J Arko; J K Rasheed; C V Broome; F W Chandler; A L Paris
Journal:  J Infect       Date:  1984-05       Impact factor: 6.072

7.  Toxic shock syndrome: modification and comparison of methods for detecting marker proteins in Staphylococcus aureus.

Authors:  M L Cohen; L M Graves; P S Hayes; R J Gibson; J K Rasheed; J C Feeley
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

8.  Recovery of staphylococcal enterotoxin F from the breast milk of a woman with toxic-shock syndrome.

Authors:  J M Vergeront; M L Evenson; B A Crass; J P Davis; M S Bergdoll; P J Wand; J H Noble; G K Petersen
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

9.  Presence of toxic shock toxin in toxic shock and other clinical strains of Staphylococcus aureus.

Authors:  M W Reeves; L Pine; J C Feeley; D E Wells
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

10.  Purification and characterization of Staphylococcus aureus FRI 1169 and 587 toxic shock syndrome exotoxins.

Authors:  H Igarashi; H Fujikawa; H Usami; S Kawabata; T Morita
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

View more
  7 in total

1.  Monoclonal antibody recognizing a species-specific protein from Streptococcus pneumoniae.

Authors:  H Russell; J A Tharpe; D E Wells; E H White; J E Johnson
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

2.  Ovine-associated Staphylococcus aureus protein with immunochemical similarity to toxic shock syndrome toxin 1.

Authors:  G Ho; W H Campbell; E Carlson
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  Oligonucleotide probes for detection and differentiation of Staphylococcus aureus strains containing genes for enterotoxins A, B, and C and toxic shock syndrome toxin 1.

Authors:  R J Neill; G R Fanning; F Delahoz; R Wolff; P Gemski
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

Review 4.  Clinical laboratory applications of monoclonal antibodies.

Authors:  W J Payne; D L Marshall; R K Shockley; W J Martin
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

5.  Rapid assay for detection of toxic shock syndrome toxin 1 from human sera.

Authors:  K Miwa; M Fukuyama; T Kunitomo; H Igarashi
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

6.  Colony immunoblot assay for the detection of staphylococcal toxic shock syndrome toxin 1 (TSST-1) with anti-TSST-1 F(ab')2 fragments.

Authors:  R H See; S Adilman; K H Bartlett; A W Chow
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

7.  Purification and characterization of a pilin specific for Brazilian purpuric fever-associated Haemophilus influenzae biogroup aegyptius (H. aegyptius) strains.

Authors:  R S Weyant; W F Bibb; D S Stephens; B P Holloway; W F Moo-Penn; K A Birkness; L O Helsel; L W Mayer
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.